Phreesia (NYSE:PHR) Stock Price Down 5.3% on Insider Selling

Shares of Phreesia, Inc. (NYSE:PHR - Get Free Report) traded down 5.3% on Thursday after an insider sold shares in the company. The company traded as low as $26.67 and last traded at $26.70. 664,138 shares changed hands during trading, an increase of 50% from the average session volume of 441,582 shares. The stock had previously closed at $28.19.

Specifically, Director Michael Weintraub sold 2,569 shares of Phreesia stock in a transaction that occurred on Tuesday, June 10th. The shares were sold at an average price of $27.86, for a total value of $71,572.34. Following the sale, the director now owns 143,039 shares of the company's stock, valued at approximately $3,985,066.54. The trade was a 1.76% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Michael Weintraub sold 7,431 shares of the business's stock in a transaction on Monday, June 9th. The shares were sold at an average price of $27.51, for a total value of $204,426.81. Following the completion of the sale, the director now owns 143,039 shares in the company, valued at approximately $3,935,002.89. The trade was a 4.94% decrease in their ownership of the stock. The disclosure for this sale can be found here.

Analyst Ratings Changes

PHR has been the subject of a number of research reports. Truist Financial increased their target price on shares of Phreesia from $34.00 to $35.00 and gave the stock a "buy" rating in a research report on Thursday, May 29th. Citigroup reaffirmed a "buy" rating on shares of Phreesia in a report on Wednesday, May 28th. Canaccord Genuity Group lowered their target price on shares of Phreesia from $35.00 to $34.00 and set a "buy" rating on the stock in a report on Thursday, May 29th. DA Davidson cut their price target on Phreesia from $36.00 to $34.00 and set a "buy" rating for the company in a report on Monday, April 14th. Finally, KeyCorp decreased their price objective on Phreesia from $30.00 to $28.00 and set an "overweight" rating on the stock in a research note on Wednesday, April 16th. Twelve research analysts have rated the stock with a buy rating, According to data from MarketBeat, the company has a consensus rating of "Buy" and a consensus target price of $31.64.

Phreesia Stock Performance

The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.74 and a current ratio of 1.74. The stock has a market cap of $1.58 billion, a PE ratio of -18.10 and a beta of 0.68. The company's 50-day moving average price is $24.97 and its two-hundred day moving average price is $25.69.

Phreesia (NYSE:PHR - Get Free Report) last posted its quarterly earnings data on Wednesday, May 28th. The company reported ($0.07) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.13) by $0.06. The firm had revenue of $115.94 million during the quarter, compared to analysts' expectations of $115.00 million. Phreesia had a negative return on equity of 32.78% and a negative net margin of 20.43%. The company's revenue for the quarter was up 14.5% compared to the same quarter last year. During the same period in the prior year, the business earned ($0.05) EPS. On average, equities research analysts forecast that Phreesia, Inc. will post -1.1 EPS for the current year.

Institutional Investors Weigh In On Phreesia

A number of hedge funds have recently made changes to their positions in the business. Johnson Financial Group Inc. raised its position in Phreesia by 381.3% in the 4th quarter. Johnson Financial Group Inc. now owns 1,131 shares of the company's stock worth $28,000 after purchasing an additional 896 shares during the period. BankPlus Trust Department bought a new position in shares of Phreesia during the fourth quarter valued at about $34,000. Quarry LP increased its holdings in shares of Phreesia by 210.9% in the fourth quarter. Quarry LP now owns 2,835 shares of the company's stock worth $71,000 after buying an additional 1,923 shares during the period. KBC Group NV bought a new stake in shares of Phreesia in the 1st quarter valued at about $74,000. Finally, Venturi Wealth Management LLC purchased a new stake in Phreesia during the 4th quarter valued at about $76,000. 92.10% of the stock is currently owned by institutional investors.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.